Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check4 days agoChange DetectedThe new screenshot shows updated entries in the Record History, with multiple updates to Study Status and Contacts/Locations for NCT04603807. These updates indicate ongoing maintenance of recruitment status and trial details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check26 days agoChange DetectedAdded a new date and a new 'Study Status Contacts/Locations' section (as of 2025-10-03), and removed an older date (2025-09-08).SummaryDifference0.9%

- Check33 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference9%

- Check40 days agoChange DetectedThe page now shows the new version label v3.1.0, replacing the old v3.0.2.SummaryDifference0.2%

- Check55 days agoChange DetectedUpdated from v3.0.1 to v3.0.2 on 2025-09-08, adding a new 'Study Status Contacts/Locations' entry (dated 2025-09-05, with 59 items) and removing the 'Back to Top' element.SummaryDifference1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.5%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.